MindMetrix
Mental Health
Assessment
for Ethan Johnson
For clinicians who don't yet use MindMetrix:
Access three assessments at no cost.
Orientation and Background
The Clinical Orientation for Providers synthesizes the relevant history you shared, current concerns, and key symptom patterns to provide a clearer understanding of your overall clinical picture.
For your Provider
Clinical Orientation: Ethan Johnson
This page was generated based on raw patient responses and the contents of this report. It is limited by the information shared by the patient and is not a substitute for clinical judgment.
Name
Date of Birth
Assessment Summary
Medications
Current: None Reported
Past: None Reported
Prior Diagnoses
Key Symptom Patterns
Persistent Inattention and Executive Dysfunction
Self-reports highlight a persistent pattern of inattention and executive dysfunction dating back to childhood. Endorsed items indicate pervasive challenges with sustained focus, task completion, and organization across daily environments.
Substance Use and Associated Role Disruption
Responses indicate frequent cannabis consumption co-occurring with cravings, tolerance, and hazardous use. Endorsed items also reflect weekly cognitive lapses and difficulties fulfilling daily expectations.
Preserved Affective Well-Being Amidst Cognitive Difficulties
Patient responses reflect an absence of depressive or anxious distress, accompanied by moderate well-being ratings. This emotional stability contrasts with substantial disruption reported in attentional and behavioral regulation.
Context to Keep in Mind
Life Factors
No current treatment was reported. Recreational use of cannabis, tobacco, and alcohol was endorsed. Reported sleep concerns include trouble waking up, with family-supported living arrangements.
Personality Traits
Disinhibition was clinically elevated, suggesting a tendency toward impulsive action, seeking immediate rewards, and low structure.
Functional Impairment
Responses suggest substantial interference with productivity, task follow-through, and meeting daily expectations across academic, occupational, and home domains.
Clinical Alerts & Validity
SUICIDAL IDEATION
None Reported
Denied ideation history
PHQ-9
Minimal or No Symptoms
ADHD VALIDITY
Review
Unusual response pattern
CHILDHOOD ADVERSITY
Review
4 of 14 ACEs endorsed
Detailed diagnostic probabilities, severity scores, and scale-level results are provided in the sections that follow.
Here’s what you told us
Self-Reported Background Information
Current Mental Health Treatment
- None reported
Current Medications
- None Reported
Cardiovascular Risk Factors
- Current: None reported
- History: None reported
- Family history: Having a cardiac pacemaker or implanted cardiac defibrillator and Other diagnosed heart problems
Pregnant, Breast-feeding, or Trying to Become Pregnant
- N/A
Sleep Issues
- Trouble waking up
Recreational Substance Use
- Cannabis / Weed (Smoking, vaping, edible, etc.)
- Tobacco (Smoking, vaping, chewing, etc.)
- Alcohol
Psychiatric Medication History
- None Reported
Diagnostic History: Mental Health Conditions
- None reported
History of Eating Disorder
- No
History of Substance Use Disorder
- No
Family Psychiatric History
- Substance use disorder
Additional Information
- I live with my dad and he doesn't care if I smoke weed
Assessment Results
- At a Glance
An Elevated Likelihood shows how much more likely you are to have the condition than the average adult in the US. To learn more about Elevated Likelihoods, visit https://mindmetrix.com/likelihood-calculation.
MindMetrix is unlikely to detect previously diagnosed conditions if the symptoms are currently well-managed by medication(s) or via other treatments, such as psychotherapy or coaching.
Only a licensed provider can synthesize all relevant health information to establish your diagnosis.
Your initial screening
Possible Explanations
for your Symptoms
The MindMetrix initial screening asked about symptoms of the following conditions. The 2 bolded conditions below warranted further testing.
Then, you completed a set of one to four tests for each condition. Your elevated likelihood was estimated based on your test results, the published accuracy rates of each test, and the condition’s prevalence in the general US adult population.
Positive
ADHD Symptom and Side Effect Tracking (ASSET)
Positive
Wender Utah Rating Scale
Positive
ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist
Positive
Cannabis Use Disorder Identification Test - Revised (CUDIT-R)
Additional Factors That May Shape Interpretation
Contextual Information
HERO Wellness Scale Higher scores indicate higher levels of wellness | 0 22 50 |
The HERO Wellness Scale is a 5-item scale that assesses well-being during the past 7 days using a five-point, Likert-type rating scale (0 = not at all; 10 = extremely). Each item measures one aspect of wellness: Happiness, enthusiasm, resilience, optimism, and mental wellness. Total scores range from 0 to 50, with higher scores reflecting higher levels of wellness. | |
Patient Health Questionnaire-9 Higher scores indicate higher levels of depressive symptoms | 0 5 27 |
The PHQ-9 is a 9-item rating scale that measures the frequency of depression symptoms experienced during the past two weeks. Individuals respond to each item using a Likert-type scale of 0 to 3 (0 = Not at all, 3 = Nearly every day). Higher scores reflect greater frequency of depression symptoms during the past two weeks. It is also frequently used in clinical settings as a general patient reported outcome measure (PROM) as it correlates with several dimensions relevant to overall wellness. | |
Adverse Childhood Experiences (ACE) Questionnaire Scores greater than zero may warrant clinical attention. Higher scores reflect exposure to a greater number of adverse childhood experiences. Review raw responses to understand the nature of these experiences.
| 0 4 10 |
The ACE Questionnaire is a 10-item self-report measure that asks about potentially stressful or traumatic experiences that occurred before age 18. The ACE score represents cumulative exposure to categories of early adversity, with a focus on maltreatment and dysfunction within the home. Research demonstrates an association between higher ACE scores and increased risk for poorer health and behavioral outcomes later in life; however, the score does not measure severity nor predict individual outcomes, and should be interpreted within the broader clinical picture. Early experiences identified may be important topics for exploration in therapy. | |
Other Childhood Adversities MindMetrix includes four additional items that assess exposure to community and structural adversities during childhood. | 0 4 |
PID-5-BF: Total Average Score Scores greater than one SD above the mean may warrant clinical attention | 0 0.8 3 |
The Personality Inventory for DSM-5 Brief Form (PID-5-BF) is a 25-item, self-report tool that assesses maladaptive personality trait expression across the five DSM-5 trait domains. Individuals respond using a four-point, Likert-type scale (0 = very false/often false; 3 = very true/often true). The Total Average score provides a single summary indicator of overall maladaptive trait expression, and each domain score is reported below. | |
Negative Affectivity A tendency to frequently experience strong negative emotions, such as anxiety, shame, guilt, or sadness. Higher scores suggest a greater tendency to feel distress easily, worry often, or struggle to recover from emotional setbacks. The opposite of negative affectivity is emotional stability.
| 0 3 |
Detachment A pattern of withdrawing from social-emotional experiences. Higher scores suggest greater tendencies to avoid closeness and casual interactions, display a limited range of emotional expression, and difficulty experiencing pleasure or joy. The opposite of detachment is extraversion.
| 0 3 |
Antagonism A tendency to behave in ways that create tension or conflict with others. Higher scores suggest a greater tendency to act in self-centered or manipulative ways, disregard others’ needs or feelings, and view relationships through a competitive or mistrustful lens. The opposite of antagonism is agreeableness.
| 0.2 3 |
Disinhibition A tendency towards instant gratification and immediate rewards. Higher scores suggest a greater tendency to act impulsively, have difficulty maintaining structure or self-control, and take unnecessary risks. The opposite of disinhibition is conscientiousness. | 0 2.6 3 |
Psychoticism A tendency to display unusual or eccentric thoughts, perceptions, or behaviors. Higher scores suggest a greater tendency to hold odd beliefs,
experience perceptual distortions, or express oneself in unconventional ways. The opposite of psychoticism is lucidity.
| 0 0.4 3 |
Subtle ADHD Malingering Screener (SAMS) Scores greater than 39 suggest an unusual response pattern | 10 49 70 |
The SAMS is a 10-item self-report scale designed to help identify individuals who endorse exaggerated or atypical ADHD traits. Scores above the cut-off suggest an unusual response pattern, which may indicate an attempt to obtain a high score on this scale. Unusual response patterns warrant further investigation, including a review of their raw responses on this scale and the ADHD symptom scales. | |
Detailed Findings
- A Closer Look
Rating scale results for each condition identified as a possible explanation for your symptoms.
Providers can review the answers to each assessment question in the Raw Responses report available on the patient page within the MindMetrix dashboard.
Possible explanation for your symptoms
Attention-Deficit/Hyperactivity Disorder (ADHD)
What it is
ADHD is a neurodevelopmental condition characterized by a persistent pattern of inattention and/or a persistent pattern of hyperactivity/impulsivity symptoms that cause impairment in social, academic, or occupational functioning.
Your Assessment Results
You initially reported symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD). You endorsed the specific characteristics of Inattentive presentation. Your responses suggest a 88.2% likelihood that Attention-Deficit/Hyperactivity Disorder (ADHD) explains your symptoms. This figure is based on your test results, the published accuracy of each measure, and the condition’s prevalence among U.S. adults. This is about 35x higher than the expected rate in the general adult population (2.5%).
ADHD Symptom and Side Effect Tracking (ASSET)
- Scores of 4.42 or greater indicate a positive screen
- Possible scores range from 1 to 6
- Timeframe: Present
Wender Utah Rating Scale
- Scores of 0.0 or greater indicate a positive screen
- Possible scores range from -5.84 to 11.88
- Timeframe: Retrospective report on childhood/adolescence
ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist
- Scores of 14 or greater indicate a positive screen
- Possible scores range from 0 to 24
- Timeframe: Past 6 months
Learn how others live with and treat the condition by visiting https://mindmetrix.com/guides/adhd-inattentive.
Possible explanation for your symptoms
Cannabis Use Disorder
What it is
Cannabis Use Disorder is a condition characterized by a problematic pattern of cannabis use (e.g., marijuana, THC vapes/pens) leading to clinically significant distress or impairments in daily life, occupational, or social functioning.
Your Assessment Results
You initially reported symptoms of Cannabis Use Disorder. Your responses suggest a 4.4% likelihood that Cannabis Use Disorder explains your symptoms. This figure is based on your test results, the published accuracy of each measure, and the condition’s prevalence among U.S. adults. This is about 2.9x higher than the expected rate in the general adult population (1.5%).
Cannabis Use Disorder Identification Test - Revised (CUDIT-R)
- Scores of 9 or greater indicate a positive screen
- Possible scores range from 0 to 32
- Timeframe: Past 6 months
Learn how others live with and treat the condition by visiting https://mindmetrix.com/guides/cannabis.
Differential
Diagnosis Steps
Differential Diagnostics - In some cases, the results of the assessment will include two or more conditions that are related, but one may rule out the other or be better explained by the other condition.
Only a licensed provider can synthesize all relevant health information to determine which diagnoses, if any, are appropriate. MindMetrix encourages healthcare providers to consider this report as one source of information in clinical decision-making. The report is not intended to serve as the sole or primary basis for diagnosis or treatment. Healthcare providers should independently evaluate all data, findings, and methodology before making clinical decisions.
For your Provider
Integrating The Findings
The clinical interview and the assessment results often make the diagnosis clear. When the picture is more complex, your provider may use the framework below as a best-practice guide to differentiate overlapping conditions and refine their diagnostic impressions.
Consider what's most impairing to the patient
(shown in order of highest to lowest impact, as inferred by patient's test responses)
Evaluate the impact of these factors
Medical Factors
Confirm each of the below is not the result of an underlying medical condition. Patient reported current medical issues of heart racing or skipping beats.
Personality factors
Disinhibition were clinically elevated.
Substance use
Patient reported use of cannabis, tobacco, and alcohol.
Current Treatment
No current treatment reported.
Strongly consider the presence of the following conditions with clear supporting data
Conditions for which all scales administered were positive and no other elevated conditions needed to be ruled out
Attention-Deficit/Hyperactivity Disorder (ADHD)
Review findings with clinician.
Cannabis Use Disorder
Review findings with clinician.
Conditions with Negative Symptom Screens
Notably, you did not report significant symptoms consistent with any of these conditions on the MindMetrix Symptom Screen. This means that, at this time, it is unlikely that these conditions are present for you, or they are currently well-managed by medications, other treatments, or coping skills.
- Acute Stress Disorder
- Adjustment Disorder
- Agoraphobia
- Alcohol Use Disorder
- Anorexia Nervosa
- Autism Spectrum Disorder (ASD)
- Binge Eating Disorder
- Bipolar I Disorder
- Bipolar II Disorder
- Body Dysmorphic Disorder
- Borderline Personality Traits
- Bulimia Nervosa
- Chronic Fatigue Syndrome (ME/CFS)
- Complex Trauma Disorder
- Cyclothymic Disorder
- Gambling Disorder
- Gender Dysphoria
- Generalized Anxiety Disorder
- Hoarding Disorder
- Insomnia
- Major Depressive Disorder
- Major Depressive Disorder with Peripartum onset
- Narcolepsy
- Obsessive-Compulsive Disorder (OCD)
- Other Bipolar-Related Disorder
- Other Eating Disorder (OSFED/UFED)
- Panic Disorder
- Persistent Depressive Disorder (Dysthymia)
- Posttraumatic Stress Disorder (PTSD)
- Psychotic Symptoms / Psychosis
- Social Anxiety Disorder
- Somatic Symptom Disorder
- Specific Phobia
- Substance Use Disorder
- Suicidal Ideation and Behavior
Rating Scale Descriptions and References
Developmental Conditions
ADHD Symptom and Side Effect Tracking (ASSET)
The ASSET is a 10-item, 2-subscale measure that assesses current ADHD symptoms using a six-point, Likert-type rating scale (1 = no problem present; 6 = severe impact). Specifically, it assesses how strongly problems with Inattention and problems with Hyperactivity/Impulsivity affect one’s daily life.
Young, J. L., Powell, R. N., Zabel, C., Saal, J., Welling, L. L., Fortain, J., & Ceresnie, A. (2023). Development and Validation of the ADHD Symptom and Side Effect Tracking-Baseline Scale (ASSET-BS): A Novel Short Screening Measure for ADHD in Clinical Populations. BMC Psychiatry 23, 806. https://doi.org/10.1186/s12888-023-05295-6
Wender Utah Rating Scale
The WURS is designed to measure an adult’s experiences with ADHD symptoms during childhood using a five-point, Likert-type rating scale. It is a retrospective self-report measure: It relies on the individual’s recollection of their experiences and behaviors as a child. Several versions are available, including a 60-item, a 53-item, and a 25-item version. The WURS Scoring requires calculating several factor scores and then calculating a “fitted value.” Fitted values that are greater than or equal to zero suggest a positive screen for ADHD symptoms during childhood. Fitted values that are less than zero (negative scores) indicate a negative screen and suggest the absence of ADHD symptoms during the developmental period.
Reimherr, F. W., Marchant, B. K., Gift, T. E., Steans, T. A., & Reimherr, M. L. (2021). Psychometric Data and Versions of the Wender Utah Rating Scale including the WURS-25 & WURS-45. Data in Brief, 107232.
ADHD Self-Report Scale (ASRS-v1.1) Symptom Checklist
The ASRS-v1.1 is an 18-item self-report rating scale used to screen adolescents and adults for symptoms of ADHD. Individuals rate how frequently they have experienced each symptom during the past 6 months using a five-point, Likert-type scale (Never = 0; Always = 4). For Adolescent clinical samples, research suggests using the weighted total scale score: Scores range from 0 to 72 and total scores of 30 or greater indicate a positive screen. For Adult samples, the literature suggests using the weighted six-item screener score is most accurate for detecting ADHD: Scores range from 0 to 24 and scores of 14 or greater suggest a positive screen.
Kessler, R. C. , Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M. J. , Jin, R., Scnik, K., Spencer, T., Ustun, T. B., & Walters, E. E. (2005). The World Health Organization adult ADHD self-report scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35(2), 245-256.
Cannabis Use Disorder Identification Test - Revised (CUDIT-R)
The CUDIT-R is an eight-item self-report questionnaire that assesses problematic cannabis use within the past 6 months. Specifically, it assesses consumption frequency, time spent high, cannabis abuse and dependence, negative consequences of use, and intention to reduce or stop use. Each item is rated using a 5-point, Likert-type scale (zero to four) with higher scores reflecting greater symptoms. For adolescents and young adults, research indicates that total scores of 6 or greater suggest a positive screen for Cannabis Use Disorder, as defined in the DSM-5.
Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, and Sellman JD. (2010). An Improved Brief Measure of Cannabis Misuse: The Cannabis Use Disorders Identification Test – Revised (CUDIT-R). Drug and Alcohol Dependence 110:137-143. | Coelho, S. G., Hendershot, C. S., Quilty, L. C., & Wardell, J. D. (2024). Screening for cannabis use disorder among young adults: Sensitivity, specificity, and item-level performance of the Cannabis Use Disorders Identification Test - Revised. Addictive behaviors, 148, 107859. https://doi.org/10.1016/j.addbeh.2023.107859
Contextual Information
Adverse Childhood Experiences (ACE) Questionnaire
The ACE Questionnaire is a 10-item self-report measure that asks about potentially stressful or traumatic experiences that occurred before age 18. The ACE score represents cumulative exposure to categories of early adversity, with a focus on maltreatment and dysfunction within the home. Research demonstrates an association between higher ACE scores and increased risk for poorer health and behavioral outcomes later in life; however, the score does not measure severity nor predict individual outcomes, and should be interpreted within the broader clinical picture. Early experiences identified may be important topics for exploration in therapy.
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., Koss, M. P., & Marks, J. S. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The Adverse Childhood Experiences (ACE) Study. American Journal of Preventive Medicine, 14(4), 245–258. https://doi.org/10.1016/S0749-3797(98)00017-8
HERO Wellness Scale
The HERO Wellness Scale is a 5-item scale that assesses well-being during the past 7 days using a five-point, Likert-type rating scale (0 = not at all; 10 = extremely). Each item measures one aspect of wellness: Happiness, enthusiasm, resilience, optimism, and mental wellness. Total scores range from 0 to 50, with higher scores reflecting higher levels of wellness.
Yaklin, S., Jain, R., Cole, S. P., Raison, C., Rolin, D., & Jain, S. (2020). HERO Wellness Scale: Examining a new mental wellness scale. Annals of clinical psychiatry: official journal of the American Academy of Clinical Psychiatrists, 32(1), 33–40. PMID: 31990967
© Copyright 2019 Saundra Jain & Rakesh Jain
Patient Health Questionnaire-9
The PHQ-9 is a 9-item rating scale that measures the frequency of depression symptoms experienced during the past two weeks. Individuals respond to each item using a Likert-type scale of 0 to 3 (0 = Not at all, 3 = Nearly every day). Higher scores reflect greater frequency of depression symptoms during the past two weeks. It is also frequently used in clinical settings as a general patient reported outcome measure (PROM) as it correlates with several dimensions relevant to overall wellness.
Beard, C., Hsu, K., Rifkin, L., Busch, A., & Björgvinsson, T. (2016). Validation of the PHQ-9 in a psychiatric sample. Journal of Affective Disorders, 193, 267–273. https://doi.org/10.1016/j.jad.2015.12.075
Personality Inventory for DSM-5 - Brief Form (PID-5-BF)
The Personality Inventory for DSM-5 Brief Form (PID-5-BF) is a 25-item, self-report tool that assesses maladaptive personality trait expression across the five DSM-5 trait domains. Individuals respond using a four-point, Likert-type scale (0 = very false/often false; 3 = very true/often true). The Total Average score provides a single summary indicator of overall maladaptive trait expression, and each domain score is reported below.
Stanton, K., Mohr, J., Towne, H., Hemphill, L., & McDonnell, C. G. (2025). Multimethod associations and psychometric properties of the Personality Inventory for DSM-5 Brief Form. Journal of Psychopathology and Behavioral Assessment, 47(1), 19. https://doi.org/10.1007/s10862-025-10199-8. Anderson, J. L., Sellbom, M., & Salekin, R. T. (2018). Utility of the Personality Inventory for DSM-5-Brief Form (PID-5-BF) in the Measurement of Maladaptive Personality and Psychopathology. Assessment, 25(5), 596–607. https://doi.org/10.1177/1073191116676889. Krueger, R. F., Derringer, J., Markon, K. E., Watson, D., & Skodol, A. E. (2012). Initial construction of a maladaptive personality trait model and inventory for DSM-5. Psychological medicine, 42(9), 1879–1890. https://doi.org/10.1017/S0033291711002674. *Measure reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision ®. (Copyright © 2022), American Psychiatric Association. All Rights Reserved. Unless authorized in writing by the APA, no part may be reproduced or used in a manner inconsistent with the APA’s copyright. This prohibition applies to unauthorized uses or reproductions in any form. The American Psychiatric Association is not affiliated with and is not endorsing this product. *DSM and DSM-5-TR are registered trademarks of the American Psychiatric Association, and are used with permission herein. Use of these trademarks is prohibited without permission of the American Psychiatric Association. Use of this trademark does not constitute endorsement of this product by the American Psychiatric Association.
Subtle ADHD Malingering Screener (SAMS)
The SAMS is a 10-item self-report scale designed to help identify individuals who endorse exaggerated or atypical ADHD traits. Scores above the cut-off suggest an unusual response pattern, which may indicate an attempt to obtain a high score on this scale. Unusual response patterns warrant further investigation, including a review of their raw responses on this scale and the ADHD symptom scales.
Ramachandran, S., Holmes, E. R., Rosenthal, M., Banahan, B. F. III, Young, J., & Bentley, J. P. (2019). Development of the Subtle ADHD Malingering Screener. Assessment, 26(3), 524–534. https://doi.org/10.1177/1073191118773881
Assessment Process and Validity Information
MindMetrix’s Assessment Process
MindMetrix uses a unique tiered assessment process that combines a public health approach to universal screening with the individualized, hypothesis-testing approach of comprehensive psychological and psychiatric assessments.
Key Symptom Detection & Daily Impact
First, MindMetrix screens individuals for over 50 psychiatric conditions using the DSM-5-based MindMetrix Symptom Screen. Both the key symptoms, and the effects of those symptoms on one’s daily life, are screened for during this phase of the assessment process.
Individualized, Condition-Specific Rating Scales
Next, individuals complete their “Individualized Test Sets" which includes several condition-specific, criterion-referenced rating scales. These scales further assess the symptoms associated with the conditions that were elevated on the individual’s MindMetrix Symptom Screening.
- Criterion-referenced assessment tools typically compare an individual’s obtained score to a “cut-off score” that was empirically-derived through scientific research. Scores falling below the cut-off usually suggest that it is unlikely the condition is present. Scores falling above the cut-off score usually suggest that the condition may be present.
Life Factors
Finally, individuals complete a series of “Life Factors" questions at the end of the MindMetrix assessment process. These demographic and socio-cultural questions about themselves and their lives are intended to aid health care providers in obtaining an accurate diagnosis and tailoring treatment to the individual.
Evidence for MindMetrix’s Validity
MindMetrix’s rigorous tiered assessment process was designed to ensure valid results are obtained in several ways.
Comprehensive Symptom Profile
- MindMetrix does not assess for just a couple symptoms or conditions: It screens individuals for the key symptoms associated with over 50 psychiatric conditions. This ensures a comprehensive symptom profile is obtained.
Aligned with the DSM-5
- Our MindMetrix Symptom Screen closely aligns with the DSM-5 diagnostic criteria for each mental health condition. It assesses for both the Key Symptoms and Daily Impact of those symptoms on one’s life.
- During the development phase, the MindMetrix Symptom Screening checklist and the Life Factors questionnaire underwent an extensive expert review process, and then pilot testing, to confirm their face-validity and accuracy.
Life Factors Assessed
- Our Life Factors questionnaire collects clinically-relevant and person-specific information. This highlights our commitment to providing culturally-competent assessment data that recognizes and values the critical roles of biological factors, psychological factors, and socio-cultural experiences in effective mental health assessment and treatment planning.
Comorbid Conditions Detected
- By screening for over 50 psychiatric conditions - and then assessing the elevated conditions further with our Individualized Test Sets - MindMetrix ensures that many clinically-relevant and potentially co-occurring conditions are not overlooked.
- By compiling this data into a user-friendly report for test-takers to share with their health care providers, MindMetrix strives to aid clinicians in minimizing the potential for diagnostic overshadowing, reducing the likelihood of confirmation bias, and increasing their diagnostic accuracy.
Empirically-Validated and Peer Reviewed Rating Scales
- Our Individualized Test Sets consist of empirically-validated rating scales that were published in peer-reviewed journals. They are highly reliable and valid measures of the specific conditions they were designed to assess.
Multiple Theoretically-Unique Measures Means Improved Accuracy & Confidence in Our Results
- To ensure independence of measurement between scales within a set, we built each test set with a selection of rating scales that each measure the construct of interest in theoretically unique ways.
- By including 2-4 rating scales per condition, MindMetrix facilitates the triangulation of data from multiple measures. This reduces measurement error, improves the accuracy of our conclusions, and increases confidence in our assessment results.
Scientifically Rigorous & Data-Driven Conclusions
- The initial screening builds hypotheses that are then assessed further using a set of carefully selected, empirically-validated rating scales.
- We’re able to calculate the statistical probability that an individual has symptoms associated with a specific condition, using the tester’s obtained score, the established clinical cut-off score, and the published sensitivity (likelihood of a “true positive”) and specificity (likelihood of a “true negative”) data for each rating scale.
- This hypothesis-driven, tiered assessment process, combined with our rigorous statistical approach, allows MindMetrix to obtain results with a high degree of confidence: MindMetrix data is able to suggest that the symptoms associated with a condition are present with approximately 90% certainty.